We Attended WADC in London

From March 3rd to 5th, we participated in the 15th World ADC conference in London as part of the Proveo group, together with Oncotec and the companies Cerbios and AGC.

The conference focused on ADCs, or Antibody-Drug Conjugates, a platform that enables the targeted delivery of highly potent chemotherapy to tumors using antibodies directed at proteins found exclusively on cancer cells.

More than 200 other companies and over 700 of their representatives attended this event, giving us a great opportunity not only to establish new connections but also to expand our knowledge of emerging trends in this specific field of pharmaceuticals, which holds great promise for the future.

We are pleased to have been part of this exciting event and believe that the insights gained, along with the new connections made, will soon be put to good use at oncomed.